Missed Us at Oslo Innovation Week?

Luckily, all our events at Oslo Innovation Week and Forskningsdagene are available for a rerun. Have a look!

We had great audiences during our three events on the 27th and 28th of September. If your were not among them, sitting in the brand new science centre of the Norwegian Cancer Society, do not despair. The events were all live streamed on Facebook. You still have a chance to experience them right here.

The events were co-hosted with our partners the Norwegian Cancer Society, the Norwegian Radium Hospital Research Foundation (Radforsk), IBM, Cancer Research UK, Norway Health Tech and EAT.

 

The first event of the week was titled “Antibiotic resistance and cancer – current status, and how to prevent a potential apocalyptic scenario”.

(function(d, s, id) { var js, fjs = d.getElementsByTagName(s)[0]; if (d.getElementById(id)) return; js = d.createElement(s); js.id = id; js.src = “//connect.facebook.net/en_US/sdk.js#xfbml=1&version=v2.10”; fjs.parentNode.insertBefore(js, fjs);}(document, ‘script’, ‘facebook-jssdk’));

Antibiotic resistance and cancer – Current status, and how to prevent a potential apocalyptic scenario #OIW2017

Posted by Kreftforeningen on Tuesday, September 26, 2017

 

Our secondary event had the title “Cancer research and innovation – benefit for patients”.

(function(d, s, id) { var js, fjs = d.getElementsByTagName(s)[0]; if (d.getElementById(id)) return; js = d.createElement(s); js.id = id; js.src = “//connect.facebook.net/en_US/sdk.js#xfbml=1&version=v2.10”; fjs.parentNode.insertBefore(js, fjs);}(document, ‘script’, ‘facebook-jssdk’));

Cancer research and innovation – benefit for patients #OIW2017

Posted by Kreftforeningen on Wednesday, September 27, 2017

 

The third and final event on our Oslo Innovation Week calendar was about how big data may transform the development of cancer treatments. 

(function(d, s, id) { var js, fjs = d.getElementsByTagName(s)[0]; if (d.getElementById(id)) return; js = d.createElement(s); js.id = id; js.src = “//connect.facebook.net/en_US/sdk.js#xfbml=1&version=v2.10”; fjs.parentNode.insertBefore(js, fjs);}(document, ‘script’, ‘facebook-jssdk’));

How Big Data may transform the development of cancer treatments #OIW2017

Posted by Kreftforeningen on Wednesday, September 27, 2017

Presentations from Cancer Crosslinks 2014

Cancer Crosslinks logo

Cancer Crosslinks 2014, January 23, was the 6th edition of this annual oncology conference bringing together hematologists, oncologists and the industry in Norway.

This years conference was developed and hosted in collaboration with partners BMS, Amgen and the Institute for Cancer Research, Oslo University Hospital. The feedback from the more than 220 participants was as always very positive, and we promise to come back with a even more exciting 7th edition of Cancer Crosslinks in January 2015.

Below you may find the main presentations featured at Cancer Crosslinks 2014, including the international keynote presentations from Professor Mario Sznol, Yale Cancer Centre and Professor Cornelis van de Velde, ECCO President. Here you may watch these presentations recorded at the Cancer Crosslinks conference.


Opening Keynotes:

“Opportunities, challenges and visions for cancer research and treatment”

Prof. Kjell Magne Tveit, Head of Department of Oncology, Oslo University Hospital

“Current trends in oncology drug development”
Prof. Gunnar Sæter, Head of the Institute for Cancer Research, Oslo University Hospital

Main session: New treatment modalities – need for a multidisciplinary approach

International Keynote:
“Cancer immunotherapies – novel treatment opportunities and their implications”
Prof. Mario Sznol, Yale Cancer Center, New Haven, CT, USA

International Keynote:

“Multidisciplinary collaboration for patient-centric oncology”
Prof. Cornelis van de Velde, Leiden University Medical Centre, Netherlands, ECCO President

“Optimizing treatment for each patient: MetAction as a Norwegian initiative”
Kjetil Boye MD, PhD; Oslo University Hospital as representative for the MetAction team
Find more info on Cancer Crosslinks 2014 here.